Hematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousStem Cell TransplantationTransplantation ConditioningGraft vs Host DiseasePeripheral Blood Stem Cell TransplantationHodgkin DiseaseTissue DonorsHematopoietic Stem CellsStem CellsMultiple MyelomaMelphalanAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyTreatment OutcomeBone Marrow TransplantationRemission InductionSalvage TherapyHematopoietic Stem Cell MobilizationHematologic NeoplasmsDisease-Free SurvivalMyeloablative AgonistsRecurrenceCyclophosphamideEtoposideLymphoma, Non-HodgkinGraft SurvivalWhole-Body IrradiationSurvival RateCytarabineLiver TransplantationCarmustineAntigens, CD34Survival AnalysisRetrospective StudiesBusulfanBone Marrow CellsVincristineThiotepaMesenchymal Stem Cell TransplantationHematopoiesisBone Marrow PurgingTransplantation ChimeraCell DifferentiationTime FactorsCord Blood Stem Cell TransplantationColony-Forming Units AssayPrognosisGranulocyte Colony-Stimulating FactorAmyloidosisLymphoma, Mantle-CellDoxorubicinCell TransplantationFollow-Up StudiesKidney TransplantationBone MarrowEmbryonic Stem CellsDexamethasoneBoronic AcidsLeukapheresisAntineoplastic Agents, AlkylatingAntibodies, Monoclonal, Murine-DerivedPyrazinesLymphoma, FollicularAdult Stem CellsAntineoplastic AgentsHistocompatibility TestingLeukemia, Myeloid, AcuteLeukemiaLymphomaAutograftsLymphoma, T-Cell, PeripheralThalidomideImmunosuppressive AgentsPrednisoneIfosfamideNeoplasm, ResidualInduction ChemotherapyHistocompatibilityMyelodysplastic SyndromesCells, CulturedPodophyllotoxinMice, Inbred C57BLLymphoma, Large B-Cell, DiffuseGraft vs Leukemia EffectHeart TransplantationT-LymphocytesPluripotent Stem CellsMesenchymal Stromal CellsSpleenMaintenance ChemotherapyCell LineageFlow CytometryVidarabineTransplantation ImmunologyLung TransplantationNeural Stem CellsStem Cell NicheProspective Studies